About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 731346, 11 pages
Research Article

Immune Responses following Stereotactic Body Radiotherapy for Stage I Primary Lung Cancer

1Department of Radiation Oncology, Kofu Municipal Hospital, 366 Masutsubo, Kofu, Yamanashi 4000832, Japan
2Department of Radiation Oncology and Radiology, University of Yamanashi, School of Medicine, 1110 Shimokato, Chu-o, Yamanashi 4093898, Japan

Received 30 April 2013; Revised 15 September 2013; Accepted 20 September 2013

Academic Editor: Ruxana T. Sadikot

Copyright © 2013 Yoshiyasu Maehata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Y. Chang and D. J. Sugarbaker, “Surgery for early stage non-small cell lung cancer,” Seminars in Surgical Oncology, vol. 21, no. 2, pp. 74–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Timmerman, R. Paulus, J. Galvin et al., “Stereotactic body radiation therapy for inoperable early stage lung cancer,” The Journal of the American Medical Association, vol. 303, no. 11, pp. 1070–1076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Onishi, H. Shirato, Y. Nagata et al., “Stereotactic body radiotherapy (SBRT) for operable Stage i non-small-cell lung cancer: can SBRT be comparable to surgery?” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. 1352–1358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Zhao, X. Yan, Y. F. Ju, et al., “Expression and clinical significance of CD3, CD4 and COX-2 in non-small cell lung cancer,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 28, pp. 407–409, 2012.
  5. M. J. Pittet, “Behavior of immune players in the tumor microenvironment,” Current Opinion in Oncology, vol. 21, no. 1, pp. 53–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Greenhough, H. J. M. Smartt, A. E. Moore et al., “The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment,” Carcinogenesis, vol. 30, no. 3, pp. 377–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. M. Yu, C. D. Yu, and Z. Q. Ling, “Elevated circulating CD19+ lymphocytes predict survival advantage in patients with gastric cancer,” Asian Pacific Journal of Cancer Prevention, vol. 13, pp. 2219–2224, 2012.
  8. H. Yoshihara, N. Tanaka, and K. Orita, “Suppression of natural killer cell activity by surgical stress in cancer patients and the underlying mechanisms,” Acta Medica Okayama, vol. 40, no. 2, pp. 113–119, 1986. View at Scopus
  9. R. E. Pollock, E. Lotzová, and S. D. Stanford, “Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors,” Cancer, vol. 70, pp. 2192–2202, 1992.
  10. T. A. Colacchio, M. P. Yeager, L. W. Hildebrandt et al., “Perioperative immunomodulation in cancer surgery,” American Journal of Surgery, vol. 167, no. 1, pp. 174–179, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. S. P. Schantz, E. J. Shillitoe, B. Brown, and B. Campbell, “Natural killer cell activity and head and neck cancer: a clinical assessment,” Journal of the National Cancer Institute, vol. 77, no. 4, pp. 869–875, 1986. View at Scopus
  12. B. A. Sandoval, A. V. Robinson, T. T. Sulaiman, R. R. Shenk, and T. A. Stellato, “Open versus laparoscopic surgery: a comparison of natural antitumoral cellular immunity in a small animal model,” American Surgeon, vol. 62, no. 8, pp. 625–631, 1996. View at Scopus
  13. M. Cristaldi, M. Rovati, M. Elli et al., “Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients,” Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, vol. 7, no. 3, pp. 255–261, 1997. View at Scopus
  14. H. A. Leaver, S. R. Craig, P. L. Yap, and W. S. Walker, “Lymphocyte responses following open and minimally invasive thoracic surgery,” European Journal of Clinical Investigation, vol. 30, no. 3, pp. 230–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. M. Eggermont, E. P. Steller, and P. H. Sugarbaker, “Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells,” Surgery, vol. 102, no. 1, pp. 71–78, 1987. View at Scopus
  16. J. P. Griffith, N. J. Everitt, F. Lancaster et al., “Influence of laparoscopic and conventional cholecystectomy upon cell- mediated immunity,” British Journal of Surgery, vol. 82, no. 5, pp. 677–680, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ben-Eliyahu, G. G. Page, R. Yirmiya, and G. Shakhar, “Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity,” International Journal of Cancer, vol. 80, no. 6, pp. 880–888, 1999. View at Scopus
  18. E. Tønnesen, “Immunological aspects of anaesthesia and surgery–with special reference to NK cells,” Danish Medical Bulletin, vol. 36, pp. 263–281, 1989.
  19. B. Lukomska, W. L. Olszewski, A. Engeset, and P. Kolstad, “The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer,” Cancer, vol. 51, no. 3, pp. 465–469, 1983. View at Scopus
  20. S. Ben-Eliyahu, G. G. Page, and S. J. Schleifer, “Stress, NK cells, and cancer: still a promissory note,” Brain, Behavior, and Immunity, vol. 21, no. 7, pp. 881–887, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Nakayama, S. Makino, Y. Fukuda et al., “Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients,” Internal Medicine, vol. 34, no. 10, pp. 959–965, 1995. View at Scopus
  22. S. Uh, S. M. Lee, H. T. Kim, et al., “The effect of radiation therapy on immune function in patients with squamous cell lung carcinoma,” Chest, vol. 105, no. 1, pp. 132–137, 1994. View at Scopus
  23. A. Kauppila, V. Raunio, and P. J. Taskinen, “Immunosuppressive effect of radiotherapy on patients with lung cancer,” Annals of Clinical Research, vol. 8, no. 2, pp. 98–103, 1976. View at Scopus
  24. K. H. Dallüge, H. J. Eichhorn, R. Ziegenbein, H. Grunau, and E. Zimek, “Lymphocyte depletion after irradiation of the chest region dependent on irradiation technics,” Strahlentherapie, vol. 160, no. 5, pp. 328–329, 1984. View at Scopus
  25. G. P. Chrousos, F. Epstein, J. Flier, S. Reichlin, and S. Pavlou, “The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation,” The New England Journal of Medicine, vol. 332, no. 20, pp. 1351–1362, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. B. C. Kennedy and G. M. Hall, “Neuroendocrine and inflammatory aspects of surgery: do they affect outcome?” Acta Anaesthesiologica Belgica, vol. 50, no. 4, pp. 205–209, 1999. View at Scopus